Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
Dana-Farber Cancer Institute
Indiana University
St. Petersburg State Pavlov Medical University
University of Washington
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of Cologne
Stanford University
Hospital Regional de Alta Especialidad del Bajio
OHSU Knight Cancer Institute
Peter MacCallum Cancer Centre, Australia
Northwestern University
Northwestern University
University of Washington
NYU Langone Health
Western Regional Medical Center